Trials / Terminated
TerminatedNCT01247649
Assessing Continuous Non- Invasive Blood Glucose Sensor- Physical Logic AG
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Rabin Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The present study is aimed to evaluate the feasibility of a new noninvasive method to measure continuous glucose values using electromagnetic radiation.
Detailed description
The non invasive continuous glucose sensing system of Physical Logic is based on a vector network analyzer (VNA), which monitor blood glucose through propriety sensors.Dielectric spectroscopy is an analytical technique whereby the electromagnetic radiation is affected by the electric dipole moment of the sample it interacts with. This method utilizes the change in the impedance of the antenna to measure the change in the relaxation processes of the interrogated medium. The VNA (vector network analyzer) , which emits non irradiating electromagnetic waves in very low power emission, is connected via standard coaxial cables to propriety sensors that are attached to the patient skin without direct contact. Study objective: To evaluate the feasibility of a new noninvasive method to measure continuous glucose values using electromagnetic radiation.The glucose values generated by the investigational non invasive devise will be compared to glucose reading of a reference devise, which measure blood glucose levels at the subcutaneous tissue. During the study we will evaluate the reliability of the study device under the conditions of alter blood glucose values in the range of 50-400 mg/dl:
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Physical Logic Continuous Glucose Monitoring System | Patients will be monitored to assess continuous blood glucose levels using the study device (Physical Logic) and reference methods, during 2-3 clinic visits, lasting 6-8 hours each |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-02-01
- Completion
- 2011-02-01
- First posted
- 2010-11-24
- Last updated
- 2012-11-20
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01247649. Inclusion in this directory is not an endorsement.